Wednesday 20 October 2021
Home      All news      Contact us      RSS     
healtheuropa - 1 month ago

Versatile Accum technology for various immune-oncology needs

Defence Therapeutics explains how its Accum™ technology can enhance the delivery of tumour and infectious disease-specific therapeutics. The principal technology developed by Defence Therapeutics (DT) is a biological drug enhancer platform, called ‘Accum’. Used in the treatment of cancer and infectious diseases, it is capable of improving the efficacy and safety of multitude biological/biosimilar-based pharmaceuticals. [ ] The post Versatile Accum technology for various immune-oncology needs appeared first on Health Europa.


Latest News
Hashtags:   

Versatile

 | 

Accum

 | 

technology

 | 

various

 | 

immune

 | 

oncology

 | 

needs

 | 

Sources